StepStone Group’s Tenaya Therapeutics TNYA Stock Holding History

StepStone Group’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$319K	Hold	462,163	–	–	0.15%	15
2025 Q4	$328K	Hold	462,163	–	–	0.18%	20
2025 Q3	$749K	Hold	462,163	–	–	0.35%	13
2025 Q2	$282K	Hold	462,163	–	–	0.56%	14
2025 Q1	$263K	Hold	462,163	–	–	0.27%	15
2024 Q4	$661K	Hold	462,163	–	–	0.58%	12
2024 Q3	$892K	Hold	462,163	–	–	0.33%	12
2024 Q2	$1.43M	Hold	462,163	–	–	0.29%	12
2024 Q1	$2.42M	Hold	462,163	–	–	0.51%	14
2023 Q4	$1.5M	Hold	462,163	–	–	0.27%	12
2023 Q3	$1.18M	Hold	462,163	–	–	0.26%	14
2023 Q2	$2.71M	Hold	462,163	–	–	0.5%	14
2023 Q1	$1.32M	Hold	462,163	–	–	0.24%	15
2022 Q4	$929K	Hold	462,163	–	–	0.12%	18
2022 Q3	$1.34M	Hold	462,163	–	–	0.19%	18
2022 Q2	$2.6M	Hold	462,163	–	–	0.28%	20
2022 Q1	$5.44M	Hold	462,163	–	–	0.41%	16
2021 Q4	$9.06M	Hold	462,163	–	–	0.52%	16
2021 Q3	$10.7M	Buy	+462,163	New	+$9.93M	0.69%	13

Other funds holding TNYA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

StepStone Group's TNYA Position: Q1 2026 in Review

StepStone Group held its Tenaya Therapeutics (TNYA) position steady in Q1 2026 at 462,163 shares worth $319K. The position accounts for 0.15% of the portfolio, ranked #15.

StepStone Group first reported a position in TNYA in Q3 2021 and has held it in 19 quarters since. The position peaked at $10.7M in Q3 2021. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

StepStone Group held 462,163 shares of Tenaya Therapeutics worth $319K as of Q1 2026.
StepStone Group left its Tenaya Therapeutics share count unchanged in Q1 2026.
Tenaya Therapeutics made up 0.15% of StepStone Group's portfolio in Q1 2026, its #15 holding.
StepStone Group first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 19 quarters since.
StepStone Group's Tenaya Therapeutics position peaked at $10.7M in Q3 2021.
103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on StepStone Group's 13F filing for Q1 2026, filed 15 May 2026.